Cite
MLA Citation
Shervin Assassi et al.. “Effect of Nintedanib on Progression of Systemic Sclerosis‐Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial.” ACR open rheumatology, vol. 4, no. 10, 2022, pp. 837–844. http://access.bl.uk/ark:/81055/vdc_100168337891.0x000002